DexCom Inc (NAS:DXCM)
$ 78.93 -1.54 (-1.91%) Market Cap: 31.43 Bil Enterprise Value: 31.12 Bil PE Ratio: 48.19 PB Ratio: 15.87 GF Score: 79/100

DexCom Inc at Cowen HealthCare Conference Transcript

Mar 02, 2020 / 08:30PM GMT
Release Date Price: $71.43 (+3.53%)
Ryan Blicker
Cowen and Company, LLC, Research Division - VP of Healthcare

All right. Good afternoon, everyone. Can you hear me? Yes? Thank you for coming. We are pleased to have Steve Pacelli and Sean Christensen with us from DexCom. We are going to do a fireside chat, and then there is the breakout in Salon K after next door. Do you guys want to make any prepared remarks? Should I dive right in?

Steven R. Pacelli
DexCom, Inc. - EVP of Strategy & Corporate Development

No. I think we just dive right in. I think most of the audience is familiar with the company. So let's just do it.

Questions & Answers

Ryan Blicker
Cowen and Company, LLC, Research Division - VP of Healthcare

Awesome. All right. I'm going to try and cover a lot of topics that we won't get to, I'm sure. But we'll start off with 2020 and some of your expectations. So you talked about on the call, 2020 guidance, assuming new patient adds are about flat year-over-year. You're capacity constrained over the course of 2019, penetration in all

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot